The rally still looks narrower than the bulls admit
Investors keep talking about a broadening market, but the cleaner read is that leadership is still too concentrated in a handful of mega-cap and thematic winners. With equal-weight still lagging, financials not taking the baton, and cyclicals failing to confirm, the tape looks more fragile than the headline indexes suggest.
The market keeps getting described as if it is in the middle of a healthy handoff. We do not buy that yet. The simplest reason is that the cap-weighted benchmark still tells a much stronger story than the average stock, and that gap matters more now that yields are back in focus and sector leadership is wobbling. If this were a true broadening phase, equal-weight, financials, and rate-sensitive cyclicals would be doing more of the heavy lifting instead of leaving the index so dependent on a narrow cluster of giants.
Start with the structure of the index itself. The S&P 500’s largest constituent now accounts for 7.9% of the benchmark, which is a reminder that headline strength can mask weak participation underneath. That is why SPY versus RSP remains the cleanest breadth test. Year to date, SPY is up 9.8% while RSP is up 8.1%. That is not a collapse in equal-weight, but it is not the kind of decisive catch-up that would let bulls declare concentration risk solved either. The market is still behaving like a cap-weighted story first and a broad-market story second.
The valuation gap reinforces the point. SPY trades at 28.19x earnings versus 22.88x for RSP, and that premium only makes sense if investors still believe the biggest names deserve to dominate the return stream. Bulls can argue that equal-weight has improved from the spring wobble, and that is fair. But improvement is not confirmation. The fact that the broad benchmark still commands a richer multiple while outperforming tells us money continues to crowd into the same leadership cohort rather than rotating cleanly across the index.
Small caps are the other place a real handoff should show up, and the picture there is better than the bears sometimes admit. IWM is up 16.8% year to date, which on the surface looks like exactly the kind of participation you want to see. Recent breadth commentary has also turned more constructive. But the same recent work still described the move as incomplete, with medium-term breadth gauges below neutral and small caps still having more to prove. That matters because a healthy broadening is not just a burst of relative performance from IWM; it is sustained confirmation that the economically sensitive part of the market can lead without constant help from the mega-cap complex. We are not there yet.
The sector handoff is even less convincing. If investors were truly rotating into a sturdier, more diversified bull phase, XLF and bellwethers like JPM should be acting better. Instead, XLF is down 5.4% year to date and JPM is down 7.6%, hardly the profile of a market where financials are taking over leadership. The same goes for rate-sensitive consumer cyclicals. HD is down 7.5% year to date, which is another sign that the parts of the market most exposed to rates and the real economy are not confirming the optimism embedded in the headline index. Bulls will say financials and housing-linked names are simply digesting higher yields, not flashing a deeper warning. Maybe. But if yields are enough to keep those groups from leading, then the broadening case is weaker than advertised by definition.
That leaves the market leaning back on the same thematic winners, especially NVDA. This is where the narrow-rally argument becomes hard to dismiss. NVDA carries a 32.21x P/E, 20.06x sales, 65.5% revenue growth, and a 63.0% net margin. Those are extraordinary numbers, and they explain why investors keep paying up. But they also underline the fragility of the current setup: when one of the market’s central pillars is still a richly valued AI infrastructure leader priced for continued elite execution, the burden on a small set of names remains very high. That is not the profile of a market that has safely diversified its leadership base.
Yes, the counterargument has some substance. Earnings participation tied to AI spending is broadening down the supply chain, and recent breadth measures have improved from the April damage. We would not argue the market is as narrow as it was at the worst point of the spring. But price leadership is what carries indexes, and recent market data still showed only 45% of S&P 500 stocks above their 20-day moving average. That is not a disaster, but it is also not the kind of robust participation that usually accompanies a durable, low-fragility advance.
The better historical rhyme is not that this is a replay of the dot-com bubble. It is that late-stage momentum markets often look healthier at the index level than they do internally. A cap-weighted benchmark can keep climbing while the average stock lags, and investors talk themselves into calling that broadening because a few secondary groups have stopped falling. But a real handoff is visible, not theoretical. It shows up in equal-weight outperforming, in financials and cyclicals taking over, and in breadth measures moving decisively into healthy territory. Right now, we have hints of that process, not proof.
The bottom line is that the rally still looks narrower than the bulls admit. SPY is still outrunning RSP, financials and rate-sensitive cyclicals are not confirming, and the market remains heavily reliant on mega-cap and AI leadership to keep the tape intact. That does not mean the rally ends tomorrow. It means the margin for error is thinner than the headline index suggests.
What would change our mind? A more durable shift in leadership from RSP, IWM, XLF, and cyclical bellwethers would do it, especially if that happened without the market needing NVDA and the rest of the mega-cap complex to rescue every wobble. Until then, our verdict is simple: this is still a concentrated advance wearing the language of broadening, and that makes it more vulnerable than many investors want to admit.
Our take, not advice. This is opinion commentary — informational only, not personalized investment recommendations. Markets carry risk. Do your own research and consider your own situation before any trade.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
